[Diabetes-Talk] Working link to Freestyle Libre app press release was RE: re heres the link to FDA approval to libre 2 app and the link is direct from abbots website

[Alan Lemly]

The problem is that apparently NFB has the Diabetes-talk list set to post in
plain text. I posted my message in html and tested the link before sending
and it worked just fine but when I received the post, only line 1 of the
link was active and the rest of it on the later lines was not. You might try
copying the link below and pasting it into the address box of your web
browser. I'll paste it below again:

 

https://abbott.mediaroom.com/2021-08-02-Abbotts-FreeStyle-R-Libre-2-iOS-App-
Cleared-in-U-S-,-Providing-a-Seamless-Digital-Experience-to-Simplify-Diabete
s-Management

 

I'll try and paste the text of the website article following my signature.

 

Alan Lemly

 

Abbott's FreeStyleR Libre 2 iOS App Cleared in U.S., Providing a Seamless
Digital Experience to Simplify Diabetes Management

- FreeStyle Libre 2 iOS app is the only sensor-based glucose monitoring app
that allows users to check their glucose with a compatible iPhone[1] every
minute with optional real-time glucose alarms[2]

- The FreeStyle Libre 2 app enables kids (ages 4 and older) and adults to
easily share their glucose data with parents and other caregivers via the
LibreLinkUp[3] app

- Free to download on the App Store, the FreeStyle Libre 2 iOS app will be
available soon

ABBOTT PARK, Ill., Aug. 2, 2021 /PRNewswire <http://www.prnewswire.com/> /
-- Abbott announced today that the U.S. Food and Drug Administration (FDA)
has cleared the FreeStyleR Libre 2 iOS application for use with compatible
iPhones1, providing a comprehensive digital offering for its FreeStyle Libre
2 integrated continuous glucose monitoring (iCGM) system
<https://c212.net/c/link/?t=0&l=en&o=3245662-1&h=2813445126&u=https%3A%2F%2F
www.abbott.com%2Ffreestyle-libre-2-continuous-glucose-monitor-cgm.html&a=Fre
eStyle+Libre+2+integrated+continuous+glucose+monitoring+(iCGM)+system> .
Providing breakthrough technology that is accessible and affordable4, the
FreeStyle Libre portfolio is the number one continuous glucose monitoring
(CGM) system worldwide5 and most prescribed in the U.S.6, changing the lives
of nearly 3.5 million people across more than 50 countries including 1
million users in the U.S. 

Approved for adults and children (4 and older) with diabetes, the new
FreeStyle Libre 2 app creates a seamless experience for users and healthcare
professionals. The app enables users to get glucose readings directly on
their iPhones without the use of a reader. A key benefit of the app is the
ability for caregivers to remotely monitor their loved one's glucose
readings and get real-time alarms via the LibreLinkUp app
<https://c212.net/c/link/?t=0&l=en&o=3245662-1&h=3885450908&u=https%3A%2F%2F
www.freestyle.abbott%2Fus-en%2Fproducts%2Ffreestyle-libre-app.html&a=LibreLi
nkUp+app> .7 

"The demands of living with diabetes
<https://c212.net/c/link/?t=0&l=en&o=3245662-1&h=2515773020&u=https%3A%2F%2F
www.abbott.com%2Fdiabetes.html&a=The+demands+of+living+with+diabetes>  can
be overwhelming, and there's a critical need to improve the way people with
diabetes manage their condition - easily, affordably, accurately - and in a
way that seamlessly fits into their everyday lives," said Jared Watkin,
senior vice president, Diabetes Care, Abbott. "The FreeStyle Libre 2 iOS app
streamlines how people manage their diabetes on their iPhones - empowering
users with the information they need 24/7 while improving their health on
the go." 

According to a recent Gallup poll, 1 in 5 Americans currently tracks health
statistics using a mobile app.8 Free to download on the iOS App Store soon,
the FreeStyle Libre 2 app will offer personalized, up-to-the-minute glucose
data for people with diabetes who are using FreeStyle Libre 2 glucose
sensors. By scanning the sensor with the  FreeStyle Libre 2 app, users will
get their current glucose reading and trend arrow which can help them
determine how food, exercise and other lifestyle factors impact diabetes
management. 

With a 14-day wear time, FreeStyle Libre 2 is the longest-lasting iCGM
sensor currently on the market.9 Available at pharmacies at a fraction of
the cost of other CGM systems,10 the FreeStyle Libre 2 system is widely
accessible to people with diabetes. Integrated features include:

*	Optional real-time glucose alarms2 that automatically alert users
when glucose is high or low 
*	Unsurpassed 14-day accuracy11 with readings every minute and an
eight-hour glucose history, including comprehensive view of trends 
*	Seamless integration with Abbott's connected digital health tools -
the LibreLinkUp app and LibreView12, a secure cloud-based data management
platform - allowing users to easily share their glucose readings with
healthcare professionals and caregivers. Accessible remotely, use of
LibreView increased about 70% over the past year.13 

"The pandemic taught us the importance of connected devices in managing
chronic conditions remotely, and we continue to see the benefit from the
latest advances in digital health," said Kurt Midyett, M.D., pediatric
endocrinologist and medical director at Midwest Pediatric Specialists.
"Continuous glucose monitoring is one of the most significant health tech
innovations in the last decade, and I see the life-changing benefits
first-hand from my patients every day. As a doctor, it's invaluable to
receive my patients' glucose data remotely via systems like LibreView -
enabling more meaningful conversations with my patients, and ultimately,
improving treatment decisions and their long-term health."

Abbott has secured partial or full reimbursement for the FreeStyle Libre
system in 38 countries, including Canada, France, Germany, Japan, the United
Kingdom, and the U.S. 

The FreeStyle Libre 2 iOS app will be available soon in the U.S. to download
on the App Store. 

Indications and Important Safety Information 

FreeStyle Libre 2 system: Failure to use FreeStyle Libre 2 system as
instructed in labeling may result in missing a severe low or high glucose
event and/or making a treatment decision, resulting in injury. If glucose
alarms and readings do not match symptoms or expectations, use a fingerstick
value from a blood glucose meter for treatment decisions. Seek medical
attention when appropriate or contact Abbott at 855-632-8658 or
https://www.FreeStyle.abbott/us-en/safety-information
<https://c212.net/c/link/?t=0&l=en&o=3245662-1&h=1305349055&u=https%3A%2F%2F
www.freestyle.abbott%2Fus-en%2Fsafety-information.html%2520for%2520safety%25
20info.&a=https%3A%2F%2Fwww.FreeStyle.abbott%2Fus-en%2Fsafety-information>
for safety info.

About Abbott: 

Abbott is a global healthcare leader that helps people live more fully at
all stages of life. Our portfolio of life-changing technologies spans the
spectrum of healthcare, with leading businesses and products in diagnostics,
medical devices, nutritionals, and branded generic medicines. Our 109,000
colleagues serve people in more than 160 countries.

Connect with us at www.abbott.com <http://www.abbott.com> , on LinkedIn at
www.linkedin.com/company/abbott-/
<https://c212.net/c/link/?t=0&l=en&o=3245662-1&h=3444161817&u=http%3A%2F%2Fw
ww.linkedin.com%2Fcompany%2Fabbott-%2F&a=www.linkedin.com%2Fcompany%2Fabbott
-%2F> , on Facebook at http://www.facebook.com/Abbott
<https://c212.net/c/link/?t=0&l=en&o=3245662-1&h=154973693&u=http%3A%2F%2Fww
w.facebook.com%2FAbbott&a=http%3A%2F%2Fwww.facebook.com%2FAbbott>  and on
Twitter @AbbottNews

1 The FreeStyle Libre 2 app is only compatible with certain mobile devices
and operating systems. Please check our website for more information about
device compatibility before using the app. Use of the FreeStyle Libre 2 app
requires registration with LibreView.
2 The High Glucose alarm level can be set between 120-400 mg/dL and the Low
Glucose alarm level can be set between 60 - 100 mg/dL Notifications will
only be received when alarms are turned on and the sensor is within 20 feet
of the reading device. Critical Alerts must be enabled to receive alarms and
alerts on the smartphone.
3 The LibreLinkUp app is only compatible with certain mobile device and
operating systems. Please check www.librelinkup.com
<http://www.librelinkup.com>  for more information about device
compatibility before using the app. Use of FreeStyle Libre-compatible apps
and LibreLinkUp may require registration with LibreView. The LibreLinkUp
mobile app is not intended to be a primary glucose monitor: users must
consult their primary device(s) and consult a healthcare professional before
making any medical interpretation and therapy adjustments from the
information provided by the app.
4 Based on a comparison of list prices of the FreeStyle Libre portfolio
versus competitor CGM systems. The actual cost to patients may or may not be
lower than other CGM systems, depending on the amount covered by insurance,
if any.
5 Data on file, Abbott Diabetes Care. Data based on the number of users
worldwide for the FreeStyle Libre system compared to the number of users for
other leading personal-use, sensor-based glucose monitoring systems
6 Data based on the number of patients assigned to each manufacturer based
on last filled prescription in US Retail Pharmacy and DME.
7 The LibreLinkUp app is only compatible with certain mobile devices and
operating systems. Please check www.LibreLinkUp.com
<http://www.LibreLinkUp.com>  for more information about device
compatibility before using the app. Use of the LibreLinkUp app requires
registration with LibreView.
8 Gallup News Service; Gallup Poll Social Series Health and Healthcare, Nov.
1 - 4, 2019
9 Data on file, Abbott Diabetes Care.
10 Based on a comparison of list prices of the FreeStyle Libre portfolio
versus competitor CGM systems. The actual cost to patients may or may not be
lower than other CGM systems, depending on the amount covered by insurance,
if any.
11 Based on FDA iCGM special controls.
12 The LibreView data management software is intended for use by both
patients and healthcare professionals to assist people with diabetes and
their healthcare professionals in the review, analysis and evaluation of
historical glucose meter data to support effective diabetes management. The
LibreView software is not intended to provide treatment decisions or to be
used as a substitute for professional healthcare advice.
13 Data on file, Abbott Diabetes Care. (Percent of PAT Accounts - percent of
Patient LibreView Accounts that enabled remote monitoring)

 

 

SOURCE Abbott